Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Organic Pharmaceutical Excipients Market Revenue Growth On Track For A 9.3% CAGR Through 2030
The organic pharmaceutical excipients market has shown significant growth in recent years. This market is expected to expand from $12.21 billion in 2025 to $13.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The surge observed in the historical period is primarily due to the rise in generic drug manufacturing, increased application of excipients in oral formulations, the availability of natural raw materials, expanding pharmaceutical production capacity, and a long-standing preference for excipients with established safety records.
The organic pharmaceutical excipients market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $18.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this projected growth include the broadening of biopharmaceutical development, a growing need for environmentally friendly drug formulations, a heightened emphasis on patient-focused drug designs, improvements in excipient manufacturing techniques, and more stringent regulations promoting the use of non-toxic excipients. Key trends during this period encompass a growing inclination towards plant-derived and natural excipients, an increasing desire for transparent and safe pharmaceutical components, greater incorporation of organic excipients in solid oral medications, the proliferation of functional excipients that improve drug stability and absorption, and increasing governmental backing for naturally obtained pharmaceutical additives.
Get A Free Sample Report With In-Depth Market Insights:
Organic Pharmaceutical Excipients Market Development Factors: What’s Supporting Demand?
The increasing requirement for pharmaceutical drugs is anticipated to drive the expansion of the organic pharmaceutical excipients market in the future. Pharmaceutical drugs are scientifically engineered substances utilized to diagnose, treat, prevent, or manage illnesses by engaging with specific biological pathways to restore or maintain physiological balance. A significant factor contributing to this escalating demand for pharmaceutical drugs is the increasing prevalence of complex and chronic health conditions, which necessitates ongoing therapeutic intervention and fosters the creation of more advanced, targeted, and accessible treatment options for long-term patient care. Organic pharmaceutical excipients support this growing need by enhancing drug stability, optimizing delivery, and boosting bioavailability, thereby enabling the efficient formulation and performance of a diverse range of contemporary medications. For instance, in January 2024, as per the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), CDER granted approval to 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, which is an increase compared to the 37 novel drug approvals in 2022. Consequently, the rising demand for pharmaceutical drugs is propelling the growth of the organic pharmaceutical excipients market.
Organic Pharmaceutical Excipients Market Segments: Where Is Growth Concentrated?
The organic pharmaceutical excipients market covered in this report is segmented –
1) By Type: Oleochemicals, Carbohydrates, Protein, Other Types
2) By Functions: Binders, Coating Agents, Colorants, Disintegrates, Other Functions
3) By Application: Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications
Subsegments:
1) By Oleochemicals: Fatty Acids, Glycerin, Fatty Alcohols, Surfactants, Esters
2) By Carbohydrates: Starch, Cellulose, Dextrins, Sugars, Pectins
3) By Protein: Gelatin, Albumin, Collagen, Casein, Whey Protein
4) By Other Types: Natural Excipients, Inorganic Excipients, Microcrystalline Cellulose
Organic Pharmaceutical Excipients Market Transformation Trends: What Innovations Are Driving Change?
Major companies in the organic pharmaceutical excipients market are focusing on developing innovative products, such as label-friendly excipient systems, to address evolving formulation needs, enhance product transparency, and support clean-label initiatives within health-related consumer markets. A label-friendly excipient system refers to a formulation-support material derived from natural or organic sources that enables the safe, stable, and effective manufacturing of drugs or supplements while aligning with consumer preferences for minimal, recognizable, and non-synthetic ingredients. For instance, in April 2023, Colorcon, a US-based pharmaceutical excipient provider, launched Nutracore, an innovative range of label-friendly excipients specifically tailored to the requirements of nutraceutical and supplement providers. These excipients are crafted from natural and organic materials to meet the growing demand for clean labeling in the nutritional and dietary supplement industry, simultaneously ensuring optimal manufacturability and performance. Nutracore excipients enable manufacturers to satisfy consumers’ label-friendly expectations without compromising on the quality and functionality of their products.
Organic Pharmaceutical Excipients Market Key Participants And Competitive Landscape
Major companies operating in the organic pharmaceutical excipients market are Roquette Frères SA, DuPont de Nemours Inc., Ashland Inc., Kerry Group plc, Evonik Industries AG, Croda International plc, Innophos Holdings Inc., Wacker Chemie AG, Merck KGaA, Colorcon Asia Private Limited, JRS PHARMA GMBH + CO KG, Cargill Incorporated, Ingredion Incorporated, Sensient Technologies Corporation, Lonza Group Ltd., DFE PHARMA INDIA PRIVATE LIMITED., Omya AG, Sigachi Industries Pvt. Ltd., Meggle AG, Archer Daniels Midland Company
View The Full Organic Pharmaceutical Excipients Market Report:
Organic Pharmaceutical Excipients Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the global organic pharmaceutical excipients market in 2025. The regions covered in the organic pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
